NovaBay Pharmaceuticals I... (NBY)
AMEX: NBY
· Real-Time Price · USD
0.59
-0.01 (-1.17%)
At close: Jun 05, 2025, 3:59 PM
0.60
1.79%
Pre-market: Jun 06, 2025, 08:46 AM EDT
-1.17% (1D)
| Bid | 0.59 |
| Market Cap | 3.46M |
| Revenue (ttm) | 7.15M |
| Net Income (ttm) | 3.66M |
| EPS (ttm) | 24.38 |
| PE Ratio (ttm) | 0.02 |
| Forward PE | -1.57 |
| Analyst | Buy |
| Ask | 0.65 |
| Volume | 34,512 |
| Avg. Volume (20D) | 49,753 |
| Open | 0.58 |
| Previous Close | 0.60 |
| Day's Range | 0.58 - 0.61 |
| 52-Week Range | 0.36 - 3.15 |
| Beta | 0.41 |
Analyst Forecast
According to 0 analyst ratings, the average rating for NBY stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts7 months ago
+18.24%
NovaBay Pharmaceuticals shares are trading higher ...
Unlock content with
Pro Subscription
8 months ago
+48.92%
NovaBay Pharmaceuticals shares are trading higher after the company announced it reached a definitive deal to sell its Avenova assets for $9.5 million.
